372 related articles for article (PubMed ID: 17499130)
21. Bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma.
Infante Cossío P; Cabezas Macián A; Pérez Ceballos JL; Palomino Nicas J; Gutiérrez Pérez JL
Med Oral Patol Oral Cir Bucal; 2008 Jan; 13(1):E52-7. PubMed ID: 18167482
[TBL] [Abstract][Full Text] [Related]
22. Maxilla osseus sequestre and oral exposure: effects of the treatment of multiple myeloma with bisphosphonates.
Lobato JV; Rodrigues JM; Cavaleiro MV; Lobato JM; Xavier L; Santos JD; Maurício AC
Acta Med Port; 2007; 20(2):185-92. PubMed ID: 17868526
[TBL] [Abstract][Full Text] [Related]
23. Consequence of therapy discontinuation in bisphosphonate-associated osteonecrosis of the jaws.
Gallego L; Junquera L
Br J Oral Maxillofac Surg; 2009 Jan; 47(1):67-8. PubMed ID: 18639371
[TBL] [Abstract][Full Text] [Related]
24. Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis.
Chiu CT; Chiang WF; Chuang CY; Chang SW
J Oral Maxillofac Surg; 2010 May; 68(5):1055-63. PubMed ID: 20403529
[TBL] [Abstract][Full Text] [Related]
25. Avascular osteonecrosis of the mandible following bisphosphonate therapy.
Chandra PA; Chandra AB; Todd GK
Am J Ther; 2009; 16(1):65-7. PubMed ID: 22573056
[TBL] [Abstract][Full Text] [Related]
26. Bisphosphonate-associated osteonecrosis. A clinician's reference to patient management.
Grewal VS; Fayans EP
N Y State Dent J; 2008 Jan; 74(1):38-44. PubMed ID: 18402375
[TBL] [Abstract][Full Text] [Related]
27. Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.
Alons K; Kuijpers SC; de Jong E; van Merkesteyn JP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Feb; 107(2):e1-7. PubMed ID: 19071040
[TBL] [Abstract][Full Text] [Related]
28. Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment.
Ficarra G; Beninati F; Rubino I; Vannucchi A; Longo G; Tonelli P; Pini Prato G
J Clin Periodontol; 2005 Nov; 32(11):1123-8. PubMed ID: 16212571
[TBL] [Abstract][Full Text] [Related]
29. Bisphosphonates, cancer, and osteonecrosis--a single practice experience.
Guarino MJ; Hill CE; Patel K
Del Med J; 2005 May; 77(5):181-7. PubMed ID: 15957261
[TBL] [Abstract][Full Text] [Related]
30. Nd:YAG laser biostimulation of bisphosphonate-associated necrosis of the jawbone with and without surgical treatment.
Vescovi P; Merigo E; Meleti M; Fornaini C; Nammour S; Manfredi M
Br J Oral Maxillofac Surg; 2007 Dec; 45(8):628-32. PubMed ID: 17524535
[TBL] [Abstract][Full Text] [Related]
31. Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis.
Hansen T; Kunkel M; Weber A; James Kirkpatrick C
J Oral Pathol Med; 2006 Mar; 35(3):155-60. PubMed ID: 16454811
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
Grant BT; Amenedo C; Freeman K; Kraut RA
J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
[TBL] [Abstract][Full Text] [Related]
33. Pathological fractures in patients caused by bisphosphonate-related osteonecrosis of the jaws: report of 3 cases.
Wongchuensoontorn C; Liebehenschel N; Wagner K; Fakler O; Gutwald R; Schmelzeisen R; Sauerbier S
J Oral Maxillofac Surg; 2009 Jun; 67(6):1311-6. PubMed ID: 19446222
[No Abstract] [Full Text] [Related]
34. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
Walter C; Al-Nawas B; Grötz KA; Thomas C; Thüroff JW; Zinser V; Gamm H; Beck J; Wagner W
Eur Urol; 2008 Nov; 54(5):1066-72. PubMed ID: 18602738
[TBL] [Abstract][Full Text] [Related]
35. [Maxillar osteonecrosis associated with bisphosphonate treatment and dental implants].
Savoldelli C; Le Page F; Santini J; Scortecci G; Odin G
Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):555-8. PubMed ID: 17631371
[TBL] [Abstract][Full Text] [Related]
36. Paget's disease and bisphosphonate-associated osteonecrosis of the jaws.
Gueiros LA; Lopes MA; Leão JC
J Oral Maxillofac Surg; 2008 Jun; 66(6):1319. PubMed ID: 18486809
[No Abstract] [Full Text] [Related]
37. Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: Report of 3 cases.
Curi MM; Cossolin GS; Koga DH; Araújo SR; Feher O; dos Santos MO; Zardetto C
J Oral Maxillofac Surg; 2007 Feb; 65(2):349-55. PubMed ID: 17236949
[No Abstract] [Full Text] [Related]
38. Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases.
Stanton DC; Balasanian E
J Oral Maxillofac Surg; 2009 May; 67(5):943-50. PubMed ID: 19375001
[TBL] [Abstract][Full Text] [Related]
39. [Bisphosphonate-associated osteonecrosis of the jaws. 3. Two case reports].
Schortinghuis J; Meijndert L; de Visscher JG; Witjes MJ
Ned Tijdschr Tandheelkd; 2007 Oct; 114(10):432-5. PubMed ID: 17972612
[TBL] [Abstract][Full Text] [Related]
40. A clinico-pathologic correlation. Bisphosphonate-related osteonecrosis of the jaws.
Oreadi D; Papageorge MB
J Mass Dent Soc; 2010; 58(4):34-7. PubMed ID: 20225801
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
